Disease-Area Clinician for Trial Endpoints Evaluation

Evaluate clinical trial endpoints and determine whether trial results would change prescribing and real-world uptake, by creating and critiquing structured rubrics that analyze commercial drugs and drug-development programs.

• Create and critique rubrics that analyze commercial drugs and drug-development programs.
• Interpret clinical trial endpoints and judge whether results would change prescribing.
• Assess implications for real-world uptake within your therapeutic area.
• Apply these assessments across the pilot''s set of drugs and development programs.

• US-based disease-area clinician, MD or DO.
• Board-certified and actively practising in your specialty.
• Deep expertise in a specific therapeutic area.
• Familiarity with biotech and pharmaceutical development programs.

• Engagement type, paid pilot with potential to continue as the work scales.
• Duration approximately 10 to 20 hours total, completed over a 1 to 2 week pilot period.
• Remote engagement, candidates should be US-based or have deep US-market experience.
• Strong contributors may be considered for recurring engagements.

• Hourly rate, 150 to 230 per hour.

• Must be a US-based practising physician, MD or DO, who is board-certified in the relevant specialty.
• Must have demonstrable expertise in the specified therapeutic area and familiarity with biotech or pharma development programs.